Your shopping cart is currently empty

D-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor and ceramide analog with potential antiproliferative activity that modulates ceramide signaling in human melanoma cells. D-NMAPPD is used in the study of colon cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $105 | 35 days | 35 days | |
| 5 mg | $388 | 35 days | 35 days | |
| 10 mg | $713 | 35 days | 35 days | |
| 50 mg | $2,790 | 35 days | 35 days |
| Description | D-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor and ceramide analog with potential antiproliferative activity that modulates ceramide signaling in human melanoma cells. D-NMAPPD is used in the study of colon cancer. |
| In vitro | In rat hippocampal slices, NMDA receptor-mediated field excitatory postsynaptic potentials (fEPSPs) at synapses in the CA1 region were significantly enhanced by pretreatment with the acidic ceramidase inhibitor D-NMAPPD. [1] |
| Synonyms | (1R,2R)-B13 |
| Molecular Weight | 422.56 |
| Formula | C23H38N2O5 |
| Cas No. | 35922-06-6 |
| Smiles | [C@@H]([C@H](NC(CCCCCCCCCCCCC)=O)CO)(O)C1=CC=C(N(=O)=O)C=C1 |
| Relative Density. | 1.101 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.